GEOGRAPHIC ATROPHY OF THE MACULA

Clinical trials for GEOGRAPHIC ATROPHY OF THE MACULA explained in plain language.

Never miss a new study

Get alerted when new GEOGRAPHIC ATROPHY OF THE MACULA trials appear

Sign up with your email to follow new studies for GEOGRAPHIC ATROPHY OF THE MACULA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Eye drop trial aims to halt blinding eye disease

Disease control Recruiting now

This study is testing whether a new eye drop medication, GAL-101, can slow the progression of geographic atrophy, a form of age-related macular degeneration that causes permanent vision loss. About 110 participants will be randomly assigned to use either the active eye drops or a…

Matched conditions: GEOGRAPHIC ATROPHY OF THE MACULA

Phase: PHASE2 • Sponsor: Galimedix Therapeutics Inc • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

GEOGRAPHIC ATROPHY OF THE MACULA

Get alerted when new GEOGRAPHIC ATROPHY OF THE MACULA trials appear

Eye drop trial aims to halt blinding eye disease